持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/02/23 | 7,190 | 7,190 | 7,110 | 7,140 | +10 | +0.1% | 15,600 |
2015/02/20 | 7,140 | 7,150 | 7,050 | 7,130 | +30 | +0.4% | 33,100 |
2015/02/19 | 6,990 | 7,120 | 6,980 | 7,100 | +100 | +1.4% | 23,200 |
2015/02/18 | 6,890 | 7,050 | 6,890 | 7,000 | +120 | +1.7% | 60,300 |
2015/02/17 | 6,810 | 6,890 | 6,770 | 6,880 | +60 | +0.9% | 16,500 |
2015/02/16 | 6,690 | 6,850 | 6,690 | 6,820 | +100 | +1.5% | 25,100 |
2015/02/13 | 6,710 | 6,770 | 6,650 | 6,720 | +10 | +0.1% | 27,700 |
2015/02/12 | 6,850 | 6,890 | 6,660 | 6,710 | -20 | -0.3% | 52,900 |
2015/02/10 | 6,760 | 6,810 | 6,710 | 6,730 | ±0 | ±0% | 29,500 |
2015/02/09 | 6,730 | 6,730 | 6,680 | 6,730 | ±0 | ±0% | 12,000 |
2015/02/06 | 6,620 | 6,780 | 6,620 | 6,730 | +110 | +1.7% | 24,100 |
2015/02/05 | 6,670 | 6,690 | 6,570 | 6,620 | -30 | -0.5% | 19,800 |
2015/02/04 | 6,630 | 6,710 | 6,610 | 6,650 | +40 | +0.6% | 23,500 |
2015/02/03 | 6,710 | 6,710 | 6,550 | 6,610 | -40 | -0.6% | 35,900 |
2015/02/02 | 6,490 | 6,670 | 6,440 | 6,650 | +160 | +2.5% | 46,600 |
2015/01/30 | 6,560 | 6,560 | 6,440 | 6,490 | +20 | +0.3% | 16,000 |
2015/01/29 | 6,430 | 6,550 | 6,410 | 6,470 | +10 | +0.2% | 21,900 |
2015/01/28 | 6,370 | 6,470 | 6,340 | 6,460 | +60 | +0.9% | 23,100 |
2015/01/27 | 6,410 | 6,410 | 6,350 | 6,400 | +70 | +1.1% | 13,400 |
2015/01/26 | 6,370 | 6,370 | 6,300 | 6,330 | -60 | -0.9% | 10,400 |
2015/01/23 | 6,350 | 6,400 | 6,270 | 6,390 | +90 | +1.4% | 18,700 |
2015/01/22 | 6,350 | 6,350 | 6,250 | 6,300 | -30 | -0.5% | 13,600 |
2015/01/21 | 6,370 | 6,380 | 6,290 | 6,330 | -80 | -1.2% | 16,600 |
2015/01/20 | 6,310 | 6,410 | 6,310 | 6,410 | +70 | +1.1% | 21,800 |
2015/01/19 | 6,310 | 6,370 | 6,310 | 6,340 | +30 | +0.5% | 9,100 |
2015/01/16 | 6,300 | 6,390 | 6,240 | 6,310 | -150 | -2.3% | 18,900 |
2015/01/15 | 6,330 | 6,480 | 6,330 | 6,460 | +160 | +2.5% | 17,100 |
2015/01/14 | 6,330 | 6,370 | 6,280 | 6,300 | -50 | -0.8% | 11,000 |
2015/01/13 | 6,270 | 6,370 | 6,180 | 6,350 | -10 | -0.2% | 22,800 |
2015/01/09 | 6,430 | 6,470 | 6,330 | 6,360 | -70 | -1.1% | 13,400 |
2015/01/08 | 6,350 | 6,460 | 6,310 | 6,430 | +140 | +2.2% | 19,400 |
2015/01/07 | 6,210 | 6,320 | 6,210 | 6,290 | +50 | +0.8% | 17,500 |
2015/01/06 | 6,350 | 6,360 | 6,240 | 6,240 | -250 | -3.9% | 30,000 |
2015/01/05 | 6,530 | 6,600 | 6,440 | 6,490 | -40 | -0.6% | 14,300 |
2014/12/30 | 6,570 | 6,590 | 6,520 | 6,530 | -30 | -0.5% | 11,100 |
2014/12/29 | 6,620 | 6,620 | 6,490 | 6,560 | -40 | -0.6% | 15,700 |
2014/12/26 | 6,620 | 6,650 | 6,590 | 6,600 | +30 | +0.5% | 11,300 |
2014/12/25 | 6,530 | 6,580 | 6,480 | 6,570 | +20 | +0.3% | 12,100 |
2014/12/24 | 6,570 | 6,570 | 6,470 | 6,550 | +60 | +0.9% | 19,500 |
2014/12/22 | 6,550 | 6,550 | 6,470 | 6,490 | -50 | -0.8% | 18,000 |
2014/12/19 | 6,550 | 6,590 | 6,520 | 6,540 | +60 | +0.9% | 16,200 |
2014/12/18 | 6,400 | 6,540 | 6,400 | 6,480 | +210 | +3.3% | 36,300 |
2014/12/17 | 6,350 | 6,430 | 6,260 | 6,270 | -100 | -1.6% | 33,600 |
2014/12/16 | 6,430 | 6,440 | 6,350 | 6,370 | -110 | -1.7% | 25,800 |
2014/12/15 | 6,470 | 6,570 | 6,460 | 6,480 | ±0 | ±0% | 26,300 |
2014/12/12 | 6,460 | 6,560 | 6,400 | 6,480 | -10 | -0.2% | 69,200 |
2014/12/11 | 6,440 | 6,520 | 6,440 | 6,490 | -10 | -0.2% | 30,200 |
2014/12/10 | 6,560 | 6,620 | 6,480 | 6,500 | -80 | -1.2% | 35,000 |
2014/12/09 | 6,560 | 6,640 | 6,540 | 6,580 | ±0 | ±0% | 24,300 |
2014/12/08 | 6,670 | 6,670 | 6,540 | 6,580 | -20 | -0.3% | 37,400 |
2551~
2600
件表示中 / 3751件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 308,500円 | +5.1% | -7.0% | 2.59% | 20.25倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 230,600円 | - | - | 0.00% | - | 106.81倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ジーエヌアイ | 280,000円 | +21.7% | +999.9% | 0.00% | 11.74倍 | 3.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 208,500円 | +3.1% | -6.5% | 2.30% | 9.67倍 | 1.03倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
JCRファーマ | 71,100円 | +14.3% | - | 2.81% | 28.90倍 | 1.85倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム